US Physical TherapyUSPH
USPH
About: US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Employees: 7,028
0
Funds holding %
of 7,202 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
56% more call options, than puts
Call options by funds: $123K | Put options by funds: $79K
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
2% less funds holding
Funds holding: 255 [Q4 2024] → 250 (-5) [Q1 2025]
2.79% less ownership
Funds ownership: 103.08% [Q4 2024] → 100.29% (-2.79%) [Q1 2025]
20% less capital invested
Capital invested by funds: $1.38B [Q4 2024] → $1.1B (-$278M) [Q1 2025]
25% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 109
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$98
24%
upside
Avg. target
$107
35%
upside
High target
$113
43%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
JMP Securities Constantine Davides | 43%upside $113 | Market Outperform Reiterated | 22 Apr 2025 |
JP Morgan Calvin Sternick | 39%upside $110 | Overweight Maintained | 19 Mar 2025 |
Barrington Research Michael Petusky | 24%upside $98 | Outperform Maintained | 28 Feb 2025 |
Financial journalist opinion
Based on 9 articles about USPH published over the past 30 days
Neutral
Zacks Investment Research
1 week ago
Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?
Investors need to pay close attention to USPH stock based on the movements in the options market lately.
Neutral
Seeking Alpha
1 week ago
U.S. Physical Therapy, Inc. (USPH) Q1 2025 Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q1 2025 Earnings Conference Call May 8, 2025 10:30 AM ET Company Participants Christopher Reading - Chairman and Chief Executive Officer Jason Curtis - Senior Vice President of Finance and Accounting Carey Hendrickson - Chief Financial Officer Eric Williams - President and Chief Operating Officer Conference Call Participants Joanna Gajuk - Bank of America Benjamin Rossi - JPMorgan Chase & Co. Brian Tanquilut - Jefferies Lawrence Solow - CJS Securities, Inc. Jared Haase - William Blair & Company Constantine Davides - Citizens JMP Securities Michael Petusky - Barrington Research Associates, Inc. Operator Good day, everyone, and thank you for standing by. Welcome to the U.S. Physical Therapy First Quarter 2025 Conference Call.
Positive
Zacks Investment Research
1 week ago
U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.51 per share a year ago.
Negative
Zacks Investment Research
1 week ago
U.S. Physical Therapy (USPH) Lags Q1 Earnings Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.51 per share a year ago.
Neutral
Business Wire
1 week ago
U.S. Physical Therapy Reports First Quarter 2025 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the first quarter ended March 31, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $19.5 million for the three months ended March 31, 2025 (“2025 First Quarter”), an increase of $2.8 million, or 1.
Neutral
GlobeNewsWire
2 weeks ago
U.S. Physical Therapy Clinics Market Analysis 2025: $53 Billion Industry Primed for Consolidation - M&A Activity Surges in Fragmented Therapy Sector
Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "U.S. Physical Therapy Clinics: An Industry Analysis" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.
Neutral
Business Wire
2 weeks ago
U.S. Physical Therapy Announces the Acquisition of an Outpatient Home Care Physical and Speech Therapy Practice
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of an outpatient home care practice that provides physical, occupational, and speech therapy through its 50%-owned subsidiary, MSO Metro, LLC (“Metro”). The practice currently generates approximately $2.1 million in annual revenues. Metro acquired an 80% interest in the acqui.
Positive
Zacks Investment Research
3 weeks ago
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
Neutral
Business Wire
3 weeks ago
U.S. Physical Therapy, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call Dates
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 8, 2025. Conference Call Date: Thursday, May 8, 2025 Time: 10:30 am Eastern /9:30 am Cent.
Positive
Zacks Investment Research
1 month ago
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Charts implemented using Lightweight Charts™